New study tracks Octreotide's Real-World impact on acromegaly over two years
Disease control
Recruiting now
This study follows 200 people with acromegaly who are using octreotide subcutaneous depot, a medication that helps control hormone levels. Researchers will monitor safety and effectiveness for up to two years in everyday clinical practice, not a controlled lab setting. The goal i…
Sponsor: Camurus AB • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC